Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.22.2.2
Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statements of Operations        
Grant revenue $ 10,675 $ 121,028 $ 186,661 $ 447,794
Cost of grant revenue 10,675 121,028 186,661 447,794
Gross profit 0 0 0 0
Operating expenses:        
Research and development 780,151 604,476 2,337,081 1,426,049
General and administrative 768,957 500,942 2,356,543 1,705,146
Sales and marketing 207,443 128,248 660,024 302,859
Total operating expenses 1,756,551 1,233,666 5,353,648 3,434,054
Loss from operations (1,756,551) (1,233,666) (5,353,648) (3,434,054)
Other income (expense):        
Interest income (expense), net 52,781 (5,012) 55,243 (6,874)
Gain on forgiveness of long-term debt     0 91,407
Total other income (expense) 52,781 (5,012) 55,243 84,533
Net loss $ (1,703,770) $ (1,238,678) $ (5,298,405) $ (3,349,521)
Net loss per share - basic $ (0.28) $ (0.20) $ (0.86) $ (0.57)
Net loss per share - diluted $ (0.28) $ (0.20) $ (0.86) $ (0.57)
Weighted average number of shares outstanding - basic 6,157,625 6,125,874 6,156,876 5,868,122
Weighted average number of shares outstanding - diluted 6,157,625 6,125,874 6,156,876 5,868,122